|
2006
ANNUAL AUTHOR INDEX
[ Topic | Author ]
[ A | B | C | D | E | F | G | H |
I | J | K | L | M | N |
O | P | Q | R | S | T | U | V | W |
X | Y | Z ]
A
Advincula AP
Robotics: the next step in the evolution of minimally invasive
gynecologic surgery. Oct:14-19
Video games, sports, and the art of surgery. Aug:13-14
Amsterdam A
Preoperative cardiac and pulmonary evaluation and risk reduction: a brief review.
Aug:15-21,40
Primary care for female cancer survivors. Feb:27-31
Anil G
Hereditary thrombophilia and thrombocythemia in pregnancy. Jul:35-39
Ansani NT, see Singh M (Jul:14-18,39)
back to top
B
Bachman G
Contraceptives can help manage abnormal menstrual bleeding. Apr(RA
suppl):10-11,18(in Spanish:10-11,18)
Managing abnormal uterine bleeding. Apr(suppl):10-12,23
Baker DA
Clinical implications and complications of undiagnosed HSV. Mar(CE
suppl):6-10
Tip of the iceberg: the startling incidence and prevalence of HSV-2.
Mar(CE suppl):3-5
Berger BA
The noncompliant patient. May:28-31
Blumenthal PD
The evolution of contraception: from potions to progestins. Oct(CE suppl):3-4
Maximizing progestin-only contraceptive success: the two-way street of counseling.
Oct(CE suppl):11-14
Bonn D, see Goldberg J (Dec:33-35)
Brooks AM
My most memorable moment: a privilege, not a burden. Dec:13
Brown HL
Overview of vaginitis: office-based DNA testing. Aug insert
Browning MF
Screening newborns for inherited metabolic disease. Dec:18-27
Brubaker L
Transvaginal reconstructive mesh: the evidence is lacking… Dec:11-12
Bullock TL
Botulinum toxin in the treatment of neurogenic and idiopathic urinary
incontinence. May:14-18,23-24,44
Bunnell M
My most memorable moment: precious. Mar:31
Burkman RT
Communication and the dissatisfied patient, part 1. Dec:28-30
The compliance conundrum. May:11-12
An ounce of prevention: axioms to consider when entering practice.
Sep:30-33
see also Clark B (Oct:42,44,75)
back to top
C
Carugno J
Laparoscopic management of ovarian ectopic pregnancy. Mar:16-20
Casper RF, see Mitwally MFM (Oct:50,55-58)
Chauhdry TA
My most memorable moment: death, despair, destruction, and a new
beginning. Oct:20,25
Chervenak FA, see Kalish
RB (Oct:45-46)
Chlebowski RT, see Geller ML (Jan:23-32)
Clark B
Depot medroxyprogesterone acetate, skeletal health, and adolescent
girls: implications of the black-box warning. Apr:36-38
Guiding adolescent contraceptive choices. Jun:35-39
Increasing use of emergency contraception. Dec:44-45
Noncontraceptive health benefits of hormonal contraception. Oct:42,44,75
Reproductive health and sexually transmitted infections in lesbian
women. Aug:38-40
Suppressing menstruation with extended hormonal contraception. Feb:38-40
Clarkson TB
Soy consumption and cholesterol levels. Aug:31-33
Collins Y, see Fajardo JE (Sep:48-52)
Cothran S, see Goldberg J (Dec:33-35)
Creinin MD, see Schreiber CA (Jan[RA
suppl]:10-12)
Crockett SA
Over-the-counter emergency contraception. Oct:47-48
back to top
D
Danner K, see Swartz C (Jan:34-36)
Darney PD
A new contraceptive implant. Oct(CE suppl):19-25
Davis A
A practical guide to thyroid disease in women. Jan:11-21
Diamond MP, see Mitwally MFM (Jun:40-46)
Dickerson VM
Don’t “just” do your job. Mar:8-9
Firsts. Feb:10-11
The green coats are coming! The green coats are coming! Apr:9-10
Dominguez L
Contraception counseling. Apr(suppl):21-23
How to talk to your provider. Apr(RA suppl):19-20(in Spanish:19-20)
What you should know about contraception. Apr(suppl):13-16
Dougherty AG, see Penzias AS (Oct:50,55-58)
back to top
E
Edelman A, see Clark B (Feb:38-40)
Elkins BL
Bacterial vaginosis: diagnosis and therapy. Aug:41-46
Ettinger B
What’s new in osteoporosis management. Oct:26-27,75
Evans RJ III
Overlapping symptoms. [interstitial cystitis/painful bladder syndrome]
Mar(RA suppl):5-7,10(in Spanish:6-9)
back to top
F
Fajardo JE
Tuberculous peritonitis mimicking ovarian cancer. Sep:48-52
Flores PA
My most memorable moment: winter headaches. May:32
Freeman R
Postmenopausal hair growth patterns. Jun:29-30
back to top
G
Gallagher R, see Sunyecz JA (Mar:21-28)
Geller ML
The role of aromatase inhibitors in breast cancer therapy. Jan:23-32
Ghulmiyyah LM
HELLP syndrome: diagnosis, management, and long-term outcome. Sep:59-64
see also Stella CL (Jul:42-48)
Glover M, see Ventolini G (Feb:12-15)
Godyn JJ, see Hazra
A (Feb:32-34)
Gold M, see Clark B (Jun:35-39)
Goldberg J
Premyomectomy uterine fibroid embolization for massive uterine
enlargement. Dec:33-35
Uterine artery embolization complicated by nontarget labial embolization.
May:26-27
Uterine artery embolization for symptomatic leiomyomata. May:45-50
Goldberg N
Practical issues in the management of dyslipidemia in women. Feb:42-46
Goldstein SR
My most memorable moment: a wealth of experience. Apr:32,35
Gonzalez IM, see Fajardo J (Sep:48-52)
Grow DR
Endometriosis, part 1: clinical diagnosis and analgesia. Nov:62-68
Endometriosis, part 2: surgery for symptom relief and infertility. Dec:54-58
Guirguis J
The United States Preventive Services Task Force: putting recommendations into
practice. May:34-38,42-44
back to top
H
Haidar ZA, see Anil G (Jul:35-39)
Hakim-Elahi E
My most memorable moment: Murphy’s law of obstetrics. Jul:33-34
Hall R, see Swartz
C (Jan:34-36)
Harer WB
Should we offer elective primary cesarean delivery? Oct:45-46
Harris JR, see Mitchell SC (Mar:10-15,49)
Hatjis CG, see Anil
G (Jul:35-39)
Hazra A
Hypereosinophilic syndrome associated with cervical squamous cell
carcinoma. Feb:32-34
Heron KL, see Hofmann LJ (Jun:19-24)
Hess LW, see Weiss PM (Jun:25-27)
Hewitt GD
The young woman’s initial gynecologic visit. Sep:25-29
Hillier SL
How birth control changes your vaginal ecosystem. Jan(RA suppl):13-16
Hofmann LJ
Missing the missing uterus. Jun:19-24
Holmes HC
Contraception: individual patients, individual choices. Apr(suppl):24-28
Lifestyle considerations for contraception choices. Apr(RA suppl):15-18(in Spanish:15-18)
Hoskins IA
Over-the-counter emergency contraception. Oct:47-48
Hsu AL, see Grow DR (Nov:62-68;
Dec:54-58)
Hughesian JH, see Burkman RT (Sep:30-33; Dec:28-30)
Hurteau J, see Fajardo JE (Sep:48-52)
back to top
J
Jenkins TR
Hysteroscopic myomectomy: a review. Jan:37-42
Jensen JT
Conclusion: finding the right contraceptive for each patient. Apr(suppl):27-28
Health benefits of hormonal contraception. Apr(suppl):5-9
Health benefits of hormonal contraception. Apr(RA suppl):6-9(in
Spanish:6-9)
Introduction: finding the right contraceptive for each patient.
Apr(suppl):3-4
Jordan B, see Clark
B (Dec:44-45)
Judge DE
Maintaining quality of life: a testimonial. [interstitial cystitis/painful
bladder syndrome] Mar(RA suppl):11-12(in Spanish:12-13)
back to top
K
Kalish RB
Should we offer elective primary cesarean delivery? Oct:45-46
Kammerer-Doak D
The practice of evidence-based medicine. Jul:10,13
Kaunitz AM, , see Clark
B (Apr:36-38)
Keehbauch J, see Thompson
KB (Oct:28-38)
Klutke CG, see Bullock
TL (May:14-18,23-24,44)
Klutke JJ, see Bullock
TL (May:14-18,23-24,44)
Koduru S, see Elkins
BL (Aug:41-46)
Kolthoff MC
Placenta accreta requiring hysterectomy following endometrial ablation. Apr:21-22,26
Komesu Y
Midurethral slings: ins, outs, ups, downs. Apr:40-47
Kouides PA
The hematologist, the gynecologist, and the patient with menorrhagia:
may the circle be unbroken. Feb:35-37
Krychman ML
Vaginal atrophy. Sep:gatefold
back to top
L
Lee C
Optimizing bone health in women with systemic lupus erythematosus.
Feb:19-23
Levine JP
Insertion and removal of the single-rod contraceptive implant.
Oct(CE suppl):26-30
Lindsay R
Bone strength: a multifactorial view. Apr:12-14
back to top
M
MacCosbe PE, see Sunyecz
JA (Mar:21-28)
Malat B, see Clark B (Jun:35-39)
Marsden DL, see Browning
MF (Dec:18-27)
Matthews EL, see Ventolini
G (Nov:35-40)
McMeekin S, see Falkner CA (May:18-26)
McCullough LB, see Chervenak FA (Aug:8-9; Nov:21-24)
Mayeaux Jr EJ, see Elkins
BL (Aug:41-46)
McCullough LB, see Kalish
RB (Oct:45-46)
Mella M, see Goldberg J (May:26-27)
Mercado R, see Carugno J (Mar:16-20)
Mielcarski E
Home delivery for patients at low risk. Dec:36-38
Mirabello J
My most memorable moment: special delivery, military style. Nov:22-23
Miranda F, see Weiss
PM (Jun:25-27)
Mitchell SC
Trimethylaminuria: a noninfectious cause of vaginal odor. Mar:10-15,49
Mitwally MFM
Clinical uses of aromatase inhibitors: beyond breast cancer. Oct:50,55-58
Moldwin RM
What is painful bladder syndrome? Mar(RA suppl):2-4,10(in Spanish:2-5)
Muench J
Metabolic effects of antipsychotic medications. Nov:46-50,55-56
back to top
N
Nader S, , see Davis A (Jan:11-21)
Neiger R, see Ventolini G (Feb:12-15)
Nelson AL
Birth control doesn’t work if you don’t use it. Jan(RA
suppl):2-4
Nonoral progestin-only methods of contraception. Oct(CE suppl):5-10
See also Schnare SM (Jan[RA suppl]:8-9)
Ninia JG
Anemia in pregnancy: an update. Oct:60-64
Nolan TE
Closure. Jan:10
back to top
P
Patel D, see Carugno
J (Mar:16-20)
Penzias AS
Evaluating amenorrhea. Jun:40-46
Pinkerton JV
Vaginal estrogen therapy: the question of systemic absorption.
Feb:24-26
Portman D
Altering the hormone-free interval with extended-cycle contraception.
Sep(suppl):1-4
back to top
R
Rako S
Is menstruation necessary? Nov:43-44
Ramanujam KP, see Ramanujam
PS (Nov:58-61)
Ramanujam PS
Management of rectal prolapse in elderly women: a study. Nov:58-61
Ramsey-Goldman R, see Lee
C (Feb:19-23)
Ravnikar VA, see Utian W (Apr[Clinical Perspectives
suppl]:1-8)
Resnick E, see Ricchetti K (Sep:53-58)
Ricchetti K
Smoking and nonrespiratory cancers in women. Sep:53-58
Rogers R, see Komesu
Y (Apr:40-47)
Rosenbaum TY
Managing postmenopausal dyspareunia: beyond hormone therapy. Nov:24-30
Rottman JS, see Hofmann LJ (Jun:19-24)
Rozen TD
Migraine: principles of treatment. Sep:16-20
back to top
S
Sand PK
Evaluation and treatment. [interstitial cystitis/painful bladder
syndrome] Mar(RA suppl):8-9(in Spanish:10-11)
Sarrel P, see Utian
W (Apr[Clinical
Perspectives suppl]:1-8)
Schmaderer J
Dietary guidelines for Americans. Sep:34-40
Schnare SM
Talking to your clinician about contraception. Jan(RA suppl):8-9
Schreiber CA
The health benefits of hormonal contraception. Jan(RA suppl):10-12
Sclar DA, see Skaer
TL (Jul:20,25-27)
Shifren JL
Testosterone therapy in postmenopausal women. Apr:29-31
Shulman LP
The culture of misinformation: an adverse influence on the health care of women.
Jun:8,13
Hormonal contraception: new alternatives to the pill. Jan(RA suppl):5-7
Ovarian cancer: it’s time to act. Nov:10-11
Sibai BM, see Stella
CL (Jul:42-48);
Ghulmiyyah LM (Sep:59-64)
Siderits R, see Hazra
A (Feb:32-34)
Simon JA, see Utian
W (Apr[Clinical
Perspectives suppl]:1-8)
Strickland JL, see Wall JW (Mar:34-38)
Simon V, see Ricchetti
K (Sep:53-58)
Singh M
Nutraceuticals and arthritis: weighing the evidence. Jul:14-18,39
Skaer TL
Anxiety disorders in women, part 1: prevalence, trends, and psychotherapy. Jul:20,25-27
Anxiety disorders in women, part 2: pharmacotherapy. Aug:23-28
Smith RL, see Mitchell SC (Mar:10-15,49)
Sreenarasimhaiah S
Intrauterine device perforation. Aug:34-37
Starz TW
Partnering to achieve a diverse and healthy geographic region. Sep:10-11
see also Singh M (Jul:14-18,39)
Stella CL
Thrombophilia and adverse maternal-perinatal outcomes. Jul:42-48
see also Ghulmiyyah LM (Sep:59-64)
Steller MA
Cervical cancer: a vaccine-preventable malignancy. Oct:9-10
Stuenkel CA
Testosterone therapy in postmenopausal women. Apr:29-31
Sulak PJ
Elimination and alteration of the hormone-free interval: reasons and methods.
Nov(suppl):1-8
The impact of the Women’s Health Initiative on the perimenopausal patient.
Dec:46-53
Is menstruation necessary? Nov:43-44
Sunyecz JA
Persistence with medication in women using daily versus weekly bisphosphonates.
Mar:21-28
Swartz C
Cervical adenocarcinoma and endometrial biopsy-site hematoma. Jan:34-36
back to top
T
Thompson KB
Evaluation and management of common breast complaints. Oct:28-38
Trolice MP
My most memorable moment: reminding us of our purpose. Sep:23-24
Tyring SK
Diagnosis and management of HSV: challenge of maximizing therapy.
Mar(CE suppl):11-16
back to top
U
Unger J, see Schmaderer
J (Sep:34-40)
Utian W
The clinical significance of Δ8,9-dehydroestrone sulfate in treating
menopausal vasomotor symptoms. Apr(Clinical Perspectives suppl):1-8
back to top
V
Venkatesh KS, see Ramanujam
PS (Nov:58-61)
Ventolini G
Intrapartum management of the growth-restricted fetus. Feb:12-15
Septic pelvic thrombophlebitis: an update. Nov:35-40
Vintzileos AM, see Yeo
L (Mar:32-36,49)
Vogt MT, see Singh M (Jul:14-18,39)
back to top
W
Waldman R
Home delivery for patients at low risk. Dec:36-38
Warren T
Genital herpes: highly stigmatized, underdiagnosed, and unrecognized.
Mar(CE suppl):17-22
Weiss PM
Understanding the basics of risk management. Jun:25-27
Werner D, see Fajardo JE (Sep:48-52)
Westhoff C
Contraceptive use: effectiveness and continuation. Apr(RA suppl):4-5(in
Spanish 4-5)
Sterilization versus regret. Apr(RA suppl):12-14(in Spanish:12-14)
Tubal sterilization: a review of the advantages and disadvantages.
Apr(suppl):17-20
Wider J, see Ricchetti
K (Sep:53-58)
Werner D, see Kolthoff MC (Apr:21-22,26)
back to top
y
Yawn BP
Postpartum depression, part 1: prevalence and considerations in screening. Mar:37-42
Postpartum depression, part 2: office interventions. Apr:48-52
see also Guirguis J (May:34-38,42-44)
Yeo L
Second-trimester genetic ultrasonography. Mar:32-36,49
back to top
|
